Open access
3,654
Views
4
CrossRef citations to date
0
Altmetric
Neurology
Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses
Imtiaz A. Samjooa EVERSANA, Burlington, Canadahttps://orcid.org/0000-0003-1415-8055
, Evelyn Worthingtona EVERSANA, Burlington, Canadahttps://orcid.org/0000-0003-1659-2082
, Anja Haltnerb EVERSANA, Sydney, Canadahttps://orcid.org/0000-0002-9829-7791
, Paul Spinb EVERSANA, Sydney, Canadahttps://orcid.org/0000-0002-4622-3547
, Christopher Drudgea EVERSANA, Burlington, Canadahttps://orcid.org/0000-0001-9721-3069
, Chris Cameronb EVERSANA, Sydney, CanadaCorrespondence[email protected]
https://orcid.org/0000-0003-3613-760X
, https://orcid.org/0000-0003-3613-760X
Róisín Brennanc Novartis Ireland, Dublin, Ireland
, Frank Dahlked Novartis Pharma AG, Basel, Switzerlandhttps://orcid.org/0000-0003-3333-6291
& Nicholas Adlardd Novartis Pharma AG, Basel, Switzerlandhttps://orcid.org/0000-0001-6912-1685
show all
Pages 1933-1944
|
Received 06 Jul 2021, Accepted 11 Aug 2021, Published online: 26 Aug 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.